The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome.

MLA

Noda, Takumi, et al. “The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome.” Journal of Clinical Medicine, vol. 11, no. 7, Mar. 2022. EBSCOhost, https://doi.org/10.3390/jcm11071847.

APA

Noda, T., Kamiya, K., Hamazaki, N., Nozaki, K., Ichikawa, T., Yamashita, M., Uchida, S., Maekawa, E., Terada, T., Reed, J. L., Yamaoka-Tojo, M., Matsunaga, A., & Ako, J. (2022). The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome. Journal of Clinical Medicine, 11(7). https://doi.org/10.3390/jcm11071847

Chicago

Noda, Takumi, Kentaro Kamiya, Nobuaki Hamazaki, Kohei Nozaki, Takafumi Ichikawa, Masashi Yamashita, Shota Uchida, et al. 2022. “The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome.” Journal of Clinical Medicine 11 (7). doi:10.3390/jcm11071847.